<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">SIROLIMUS</span><br/>(sir-o-li'mus)<br/><span class="topboxtradename">Rapamune<br/></span><b>Classifications:</b> <span class="classification">immunomodulator</span>; <span class="classification">immunosuppressant</span><br/><b>Prototype: </b>Cyclosporine<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>1 mg tablets; 1 mg/mL oral solution</p>
<h1><a name="action">Actions</a></h1>
<p>Macrolide antibiotic structurally related to tacrolimus with immunosuppressive activity. Active in reducing a transplant rejection
         by inhibiting the response of helper T-lymphocytes and B-lymphocytes to cytokinesis [(interleukin) IL-2, IL-4, and IL-5].
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Inhibits antibody production and acute transplant rejection reaction in autoimmune disorders [e.g., systemic lupus erythematosus
         (SLE)]. Indicated by nonrejection of transplanted organ.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Prophylaxis of kidney transplant rejection.</p>
<h1><a name="unlabeleduses">Unlabeled Uses</a></h1>
<p>Treatment of psoriasis.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to sirolimus; lung or liver transplant patients; soya lecithin (soy fatty acids) hypersensitivity; lymphoma,
         neoplastic disease; children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Hypersensitivity to or concurrent administration with tacrolimus; impaired renal function; concurrent use of aminoglycosides,
         and amphotericin B; renal transplant patients; dialysis patients, UV exposure, retransplant patients, multiorgan transplant
         recipients, African-American transplant patients; viral or bacterial infection; hypertriglyceridemia, hyperlipidemia, diabetic
         patients, atrial fibrillation, CHF, hypervolemia, palpitations; mild to moderate hepatic disease; coronary artery disease;
         myelosuppression; liver disease.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Kidney Transplant</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 6 mg loading dose immediately after transplant, then 2 mg/d. Doses will need to be much higher (up to 40 mg/d) if not on cyclosporine<br/><span class="rdage">Adolescent:</span> <span class="rdroute">PO</span> <img src="../images/special/greaterorequal.gif"/><i>13 y and  3 mg/m<sup>2</sup> loading dose immediately after transplant, then 1 mg/m<sup>2</sup>/d. Doses will need to be much higher (up to 40 mg/d) if not on cyclosporine<br/><br/><span class="impairmenttitle">Hepatic Impairment</span><br/>Reduce maintenance dose by 33%<br/><br/></i></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give 4 h after oral cyclosporine.</li>
<li>Add prescribed amount of sirolimus to a glass containing <img src="../images/special/greaterorequal.gif"/>2 oz (60 mL) of
            water or orange juice (do not use any other type of liquid). Stir vigorously and administer immediately. Refill glass with
            <img src="../images/special/greaterorequal.gif"/>4 oz (120 mL) of water or orange juice. Stir vigorously and administer immediately.
         </li>
<li>Give consistently with respect to amount and type of food.</li>
<li>Refrigerate; protect from light; use multidose bottles within 1 mo of opening.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span>
<span class="speceff-common">Asthenia, back pain, chest pain, fever, pain, arthralgia;</span> flu-like syndrome; generalized edema; infection; lymphocele; malaise; <span class="speceff-life">sepsis</span>, arthrosis, bone necrosis, leg cramps, myalgia, osteoporosis, tetany, abscess, ascites, cellulitis, chills, face edema, hernia,
      pelvic pain, peritonitis. <span class="typehead">CNS:</span>
<span class="speceff-common">Insomnia, tremor, headache,</span> anxiety, confusion, depression, dizziness, emotional lability, hypertonia, hyperesthesia, hypotonia, neuropathy, paresthesia,
      somnolence. <span class="typehead">CV:</span>
<span class="speceff-common">Hypertension,</span> atrial fibrillation, CHF, hypervolemia, hypotension, palpitation, peripheral vascular disorder, postural hypotension, syncope,
      tachycardia, thrombophlebitis, thrombosis, vasodilation. <span class="typehead">GI:</span>
<span class="speceff-common">Constipation, diarrhea, dyspepsia, nausea, vomiting, abdominal pain,</span> anorexia, dysphagia, eructation, esophagitis, flatulence, gastritis, gastroenteritis, gingivitis, gum hyperplasia, ileus,
      mouth ulceration, oral moniliasis, stomatitis, abnormal liver function tests. <span class="typehead">Hematologic:</span>
<span class="speceff-common">Anemia,</span>
<span class="speceff-common">thrombocytopenia,</span>
<span class="speceff-life">leukopenia</span>, hemorrhage, ecchymosis, leukocytosis, lymphadenopathy, polycythemia, thrombotic, thrombocytopenic purpura. <span class="typehead">Metabolic:</span>
<span class="speceff-common">Edema, hypercholesterolemia, hyperkalemia, hyperlipidemia, hypokalemia, hypophosphatemia, peripheral edema, weight gain,</span> Cushing's syndrome, diabetes, acidosis, hypercalcemia, hyperglycemia, hyperphosphatemia, hypocalcemia, hypoglycemia, hypomagnesemia,
      hyponatremia; increased LDH, alkaline phosphatase, BUN, creatine phosphokinase, ALT, or AST; weight loss. <span class="typehead">Respiratory:</span>
<span class="speceff-common">Dyspnea, pharyngitis, upper respiratory tract infection,</span> asthma, atelectasis, bronchitis, cough, epistaxis, hypoxia, lung edema, pleural effusion, pneumonia, rhinitis, sinusitis. <span class="typehead">Skin:</span>
<span class="speceff-common">Acne, rash,</span> fungal dermatitis, hirsutism, pruritus, skin hypertrophy, skin ulcer, sweating. <span class="typehead">Urogenital:</span>
<span class="speceff-common">UTI,</span> albuminuria, bladder pain, dysuria, hematuria, hydronephrosis, impotence, kidney pain, nocturia, renal tubular necrosis,
      oliguria, pyuria, scrotal edema, incontinence, urinary retention, glycosuria. <span class="typehead">Special Senses:</span> Abnormal vision, cataract, conjunctivitis, deafness, ear pain, otitis media, tinnitus. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> Sirolimus concentrations increased by <b>clarithromycin,</b>
<b> cyclosporine,</b>
<b>diltiazem,</b>
<b>erythromycin,</b>
<b>ketoconazole,</b>
<b>itraconazole,</b>
<b> telithromycin;</b> sirolimus concentrations decreased by <b>rifabutin,</b>
<b> rifampin;</b>
<span class="classification">vaccines</span> may be less effective with sirolimus; <b>tacrolimus</b> increases mortality, hepatic artery thrombosis, and graft loss. <span class="typehead">Food:</span>
<b>Grapefruit juice</b> significantly decreases absorption of sirolimus. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Rapidly absorbed with 14% bioavailability. <span class="typehead">Peak:</span> 2 h. <span class="typehead">Distribution:</span> 92% protein bound, distributes in high concentrations to heart, intestines, kidneys, liver, lungs, muscle, spleen, and
      testes. <span class="typehead">Metabolism:</span> Metabolized in liver by CYP3A4. <span class="typehead">Elimination:</span> 91% excreted in feces, 2.2% in urine. <span class="typehead">Half-Life:</span> 62 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor for S&amp;S of graft rejection.</li>
<li>Control hyperlipidemia prior to initiating drug.</li>
<li>Draw trough whole-blood sirolimus levels 1 h before a scheduled dose.</li>
<li>Lab tests: Obtain periodic lipid profile, CBC with differential, fasting plasma glucose, blood chemistry, BUN, and creatinine
            (especially with other drugs known to cause renal impairment).
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Avoid grapefruit juice within 2 h of taking sirolimus.</li>
<li>Limit exposure to sunlight (UV exposure).</li>
<li>
            							Note: Decreased effectiveness possible for vaccines during therapy.
            						
         </li>
<li>Use or add barrier contraceptive before, during, and for 12 wk after discontinuing therapy.</li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>